(READ) FDA approves 1st monthly shot to prevent HIV

The following is from Medpage. The first long-acting injectable for HIV prevention has now been approved for use, the FDA announced on Monday. Long-acting injectable cabotegravir (CAB-LA, branded as Apretude) is administered as a monthly injection for the first 2 months, then every 2 months afterwards. It is the first long-acting injectable for pre-exposure prophylaxis (PrEP). […]

Continue reading (READ) FDA approves 1st monthly shot to prevent HIV on sharylattkisson.com.